Sequential Fluorescence In Situ Hybridization Analysis for Trisomy 12 in B-Cell Chronic Lymphocytic Leukemia
Tumor-specific chromosomal abnormalities are attracting a large interest owing to the diagnostic, prognostic, and therapeutic importance. The development of molecular techniques, e.g., fluorescence in situ hybridization (FISH), have improved the detection of specific chromosomal abnormalities in chronic lymphocytic leukemic (CLL). By using FISH, the problem with tumor cells with low mitotic rate is avoided since this method readily detects clonal aberrations also in nondividing, interphase cells. Three different types of probes are used: (1) centromeric probes for numerical chromosome abnormalities, (2) whole chromosome paints, and (3) locusspecific probes. The DNA probes are labeled with fluorochromes and the signals yielded are strong enough to enable analysis of interphase cells. These DNA probes may be directed towards any defined chromosomal region and this chapter will in detail describe the FISH method as a detector of trisomy 12 in CLL.
- Reciprocal Subtraction Differential RNA Display (RSDD): An Efficient Technology for Cloning Differentially Expressed Genes
- Peptide YY Mediates Inhibition of Tumor Growth and Inflammation
- Impact of Breast Cancer Resistance Protein on Cancer Treatment Outcomes
- Determination of Cyclin D1 Expression by Quantitative Real-Time, Reverse-Transcriptase Polymerase Chain Reaction
- SSCP and Sequence Analysis of p53 Mutations in Ovarian Tumors
- Small-Cell Lung Cancer (SCLC) Cell Adhesion on E- and P-Selectin Under Physiological Flow Conditions
- Cytogenetic Studies Using FISH: Background
- Application of Proteomics in Cancer Gene Profiling: Two-Dimensional Difference in Gel Electrophoresis (2D-DIGE)
- 液体闪烁仪的探测下限
- 诱导多能干细胞